Health / Medical Topics

    Serious Adverse Event

    Any expected or unexpected adverse event, related or unrelated to the intervention, occurring at any agent dose, any phase of product or procedure testing, that results in any of the following outcomes: death, a life-threatening adverse event, requires inpatient hospitalization (not required as part of the treatment) or prolongation of existing hospitalization, a persistent or significant disability or incapacity, or cancer, or a congenital anomaly or birth defect. Important medical events that may not result in the listed outcomes may be considered as serious when, based upon appropriate medical judgment, they represent significant hazards or potentially serious harm to the research subject or others and may require medical intervention to prevent one of the outcomes listed in this definition. (NCI Thesaurus)




    YOU MAY ALSO LIKE

    Causing fear or anxiety by threatening great harm; of great consequence.
    Serine/threonine-protein phosphatase PP1-alpha catalytic subunit (330 aa, ~38 kDa) is encoded by the human PPP1CA gene. This protein is involved in protein…
    Serine/threonine-protein phosphatase 6 catalytic subunit (305 aa, ~35 kDa) is encoded by the human PPP6C gene. This protein plays a role in…
    Serine/threonine-protein phosphatase 2A regulatory subunit B double prime subunit beta (575 aa, ~65 kDa) is encoded by the human PPP2R3B gene. This…
    Serine/threonine-protein phosphatase 2A activator (358 aa, ~41 kDa) is encoded by the human PPP2R4 gene. This protein plays a role in both…
    Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform (601 aa, ~66 kDa) is encoded by the human PPP2R1B gene. This…

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact